References
- A
ckman J.D., Russman B.S., Thomas S.S., Buckon C.E., Sussman M.D., Masso P., Sanders J., D’Astous J., Aiona M.D., Shriners Hospitals BTX-A Study Group. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy, Dev. Med. Child Neurol., 2005, 47 (9), 620–627. PMID: 16138670. - A
lmina S., Karile Y., Audrone P., Indre B., Analgesic effect of botulinum toxin in children with cerebral palsy: A systematic review, Toxicon, 2021, Aug., 199, 60–67, DOI: 10.1016/j.toxicon.2021.05.012. - B
lumetti F.C., Belloti J.C., Tamaoki M.J., Pinto J.A., Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy, Cochrane Database Syst. Rev., 2019, 10 (10), CD001408, DOI: 10.1002/14651858. CD001408.pub2. - B
lumetti F.C., Belloti J.C., Tamaoki M.J., Pinto J.A., Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy, Cochrane Database Syst. Rev., 2019, 10 (10), CD001408, DOI: 10.1002/14651858.CD001408.pub2. - B
onikowski M., Sławek J., Safety and efficacy of Botulinum toxin type A preparations in cerebral palsy – an evidence-based review, Neurol. Neurochir. Pol., 2021, 55 (2), 158–164, DOI: 10.5603/PJNNS.a2021.0032. - B
ooth M.Y., Yates C.C., Edgar T.S., Bandy W.D., Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children, Pediatr. Phys. Ther., 2003, 15 (4), 216–220, DOI: 10.1097/01.PEP.0000096382.65499.E2. - C
ahlin B.J., Lindberg C., Dahlström L., Cerebral palsy and bruxism: Effects of botulinum toxin injections – A randomized controlled trial, Clin. Exp. Dent. Res., 2019, 5 (5), 460–468, DOI: 10.1002/cre2.207. - D
ursun N., Gokbel T., Akarsu M., Bonikowski M., Pyrzanowska W., Dursun E., Intermittent serial casting for wrist flexion deformity in children with spastic cerebral palsy: a randomized controlled trial, Dev. Med. Child. Neurol., 2021, 63 (6), 743–747, DOI: 10.1111/dmcn.14765. - F
arag S.M., Mohammed M.O., El -Sobky T.A., El Kadery N.A., El Zohiery A.K., Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials, JBJS Rev., 2020, 8 (3), e0119, DOI: 10.2106/JBJS.RVW.19.00119. - F
athi M., Hussein A.S., M Elghazaly S., Al -Kinawy A.M., Abdeltawab A.K., Mansour Y.M., Elbehbeh N.A., Sherif A., Afifi A.M., Effect of Botulinum Toxin on Equinus Foot Deformity in Cerebral Palsy Patients: A Systematic Review and Network Meta-analysis, Curr. Pharm. Des., 2020, 26 (37), 4796–4807, DOI: 10.2174/1381612826666200518105633. - F
ranzén M., Hägglund G., Alriksson -Schmidt A., Treatment with Botulinum toxin A in a total population of children with cerebral palsy – a retrospective cohort registry study, BMC Musculoskelet. Disord., 2017, 18 (1), 520, DOI: 10.1186/s12891-017-1880-y. - G
ulati S., Sondhi V., Cerebral Palsy: An Overview, Indian J. Pediatr., 2018, 85 (11), 1006–1016, DOI: 10.1007/s12098-017-2475-1. - H
ägglund G., Hollung S.J., Ahonen M., Andersen G.L., Eggertsdóttir G., Gaston M.S., Jahnsen R., Jeglinsky -Kankainen I., Nordbye -Nielsen K., Tresoldi I., Alriksson -Schmidt A.I., Treatment of spasticity in children and adolescents with cerebral palsy in Northern Europe: a CP-North registry study, BMC Neurol., 2021, 21 (1), 276, DOI: 10.1186/s12883-021-02289-3. - L
ee S.J., Sung I.Y., Jang D.H., Yi J.H., Lee J.H., Ryu J.S., The effect and complication of botulinum toxin type a injection with serial casting for the treatment of spastic equinus foot, Ann. Rehabil. Med., 2011, 35 (3), 344–353, DOI: 10.5535/arm.2011.35.3.344. - M
athevon L., Bonan I., Barnais J.L., Boyer F., Dinomais M., Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review, Ann. Phys. Rehabil. Med., 2019, 62 (4), 283–290, DOI: 10.1016/j.rehab.2018.06.010. - M
ilne N., Miao M., Beattie E., The effects of serial casting on lower limb function for children with Cerebral Palsy: a systematic review with meta-analysis, BMC Pediatr., 2020, 20 (1), 324, DOI: 10.1186/s12887-020-02122-9. - M
ultani I., Manji J., Hastings -Ison T., Khot A., Graham K., Botulinum Toxin in the Management of Children with Cerebral Palsy, Paediatr. Drugs, 2019, 21 (4), 261–281, DOI: 10.1007/s40272-019-00344-8. - M
ultani I., Manji J., Tang M.J., Herzog W., Howard J.J., Graham H.K., Sarcopenia, Cerebral Palsy, and Botulinum Toxin Type A, JBJS Rev., 2019, 7 (8), e4, DOI: 10.2106/JBJS.RVW.18.00153. - N
icolini -Panisson R.D., Tedesco A.P., Folle M.R., Donadio M.V.F., Selective Dorsal Rhizotomy in Cerebral Palsy: Selection Criteria and Postoperative Physical Therapy Protocols, Rev. Paul Pediatr., 2018, 36 (1), 9, DOI: 10.1590/1984-0462/;2018;36;1;00005. - P
ark E.S., Rha D.W., Yoo J.K., Kim S.M., Chang W.H., Song S.H., Short-term effects of combined serial casting and botulinum toxin injection for spastic equinus in ambulatory children with cerebral palsy, Yonsei Med. J., 2010, 51 (4), 579–584, DOI: 10.3349/ymj.2010.51.4.579. - P
érez -de la Cruz S., Childhood cerebral palsy and the use of positioning systems to control body posture: Current practices, Neurologia. 2017, 32 (9), 610–615, English, Spanish, DOI: 10.1016/j.nrl.2015.05.008. - R
osenbaum P., Paneth N., Leviton A., Goldstein M., Bax M., Damiano D., Dan B., Jacobsson B., A report: the definition and classification of cerebral palsy April 2006, Dev. Med. Child Neurol. Suppl., 2007, 109, 8–14. Erratum in: Dev. Med. Child. Neurol., 2007, 49 (6), 480, PMID: 17370477. - S
adowska M., Sarecka -Hujar B., Kopyta I., Cerebral Palsy: Current Opinions on Definition, Epidemiology, Risk Factors, Classification and Treatment Options, Neuropsychiatr Dis. Treat., 2020, 16, 1505–1518, DOI: 10.2147/NDT.S235165. - S
chweizer M., Eylon S., Katz -Leurer M., The correlation between rhythm perception and gait characteristics at different rhythms among children with cerebral palsy and typically developing children, Gait Posture, 2020, 82, 83–89, DOI: 10.1016/j.gaitpost.2020.08.120. - S
hoval H., Friel K., Levin J., Kim H., Cumulative Efficacy of Longitudinal Repeat Salivary Gland Onabotulinumtoxin A Injection: A Retrospective Study, Am. J. Phys. Med. Rehabil., 2021, 100 (8), 798–802, DOI: 10.1097/PHM.0000000000001675. - S
hoval H., Levin J., Friel K., Kim H., Safety of combined salivary gland and multilevel intramuscular onabotulinumtoxinA injections with and without ethanol in pediatric patients with cerebral palsy: A retrospective study, J. Pediatr. Rehabil. Med., 2019, 12 (2),189–196, DOI: 10.3233/PRM-180552. - T
horley M., Donaghey S., Edwards P., Copeland L., Kentish M., Mc Lennan K., Lindsley J., Gascoigne -Pees L., Sakzewski L., Boyd R.N., Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial, BMC Pediatr., 2012, 9, 12, 120, DOI: 10.1186/1471-2431-12-120. - W
esseling M., Kainz H., Hoekstra T., Van Rossom S., Desloovere K., De Groote F., Jonkers I., Botulinum toxin injections minimally affect modelled muscle forces during gait in children with cerebral palsy, Gait Posture, 2020, 82, 54–60, DOI: 10.1016/j.gaitpost.2020.08.122. - Y
adav S., Chand S., Majumdar R., Sud A., Effect of botulinum toxin type-A in spasticity and functional outcome of upper limbs in cerebral palsy, J. Clin. Orthop. Trauma, 2020, 11 (2), 208–212, DOI: 10.1016/j.jcot.2020.01.002. - Y
iğitoğlu P., Kozanoğlu E., Effectiveness of electrical stimulation after administration of botulinum toxin in children with spastic diplegic cerebral palsy: A prospective, randomized clinical study, Turk. J. Phys. Med. Rehabil., 2019, 65 (1), 16–23, DOI: 10.5606/tftrd.2019.2236.